CCO Infectious Disease Podcast

Answering the Questions on Which HIV PrEP for Which Patient: Latesha Elopre and Jason Farley

Episode Summary

Hear from expert faculty as they answer questions and discuss key considerations for determining PrEP candidacy, choosing among PrEP options, and addressing PrEP persistence for individual patients.

Episode Notes

In this episode, Latesha Elopre, MD, MSPH, and Jason Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN, answer questions about HIV PrEP including:

• How long someone can receive PrEP and the monitoring that is needed over time
• Recommendations for monitoring bone health while receiving oral PrEP
• Treatment as prevention and PrEP efficacy data and options for people who inject drugs
• The role of circumcision in HIV prevention
• The use of PrEP in pregnancy
• Concern for ART resistance if someone seroconverts while receiving PrEP, especially when using nondaily PrEP options
• The possibility of using FTC/TAF on demand
• Inequities in adherence and persistence
• Cost considerations with different PrEP modalities
• Recommendations for hospitalized patients receiving PrEP
• PrEP considerations for patients with renal dysfunction and higher BMIs
• PrEP efficacy based on site of exposure

Presenters:

Latesha Elopre, MD, MSPH
Associate Professor
Division of Infectious Diseases
Assistant Dean of Diversity and Inclusion
General Medical Education
University of Alabama at Birmingham
Birmingham, Alabama

Jason Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN
Professor
School of Nursing
Johns Hopkins University
Nurse Practitioner
Department of Infectious Diseases
John G. Bartlett Specialty Practice
Baltimore, Maryland

Link to full program:
https://bit.ly/3Fqdgs9